Nalini Vadivelu1, Alice M Kai2, Gopal Kodumudi3, Julie Sramcik4, Alan D Kaye5. 1. Department of Anesthesiology, Yale University, TMP3 333, Cedar Street, New Haven, CT, 06520, USA. nalini.vadivelu@yale.edu. 2. Department of Internal Medicine, NYU Winthrop Hospital, 259 First Street, Mineola, NY, 11501, USA. 3. California Northstate University College of Medicine, 9700 West Taron Drive, Elk Grove, CA, 95757, USA. 4. Department of Anesthesiology, Yale University, TMP3 333, Cedar Street, New Haven, CT, 06520, USA. 5. Department of Anesthesiology, Louisiana State University Health Sciences Center, 1542 Tulane Ave, Suite 656, New Orleans, LA, 70112, USA.
Abstract
PURPOSE OF REVIEW: The purpose of the following review is to summarize the history and current policies related to marijuana use and prevalence, basic and clinical science pharmacological literature regarding efficacy, subpopulations of concern, and varying policies regarding its use at present. RECENT FINDINGS: With the increasingly widespread utilization of marijuana, there is also a growing complexity of public health policy, regulation, and necessity to further assess the medical indications and adverse long-term effects of marijuana use. Health care providers as well as the general public must be prepared to become familiar and up-to-date with medical literature, legislation, and educational material regarding medical marijuana.
PURPOSE OF REVIEW: The purpose of the following review is to summarize the history and current policies related to marijuana use and prevalence, basic and clinical science pharmacological literature regarding efficacy, subpopulations of concern, and varying policies regarding its use at present. RECENT FINDINGS: With the increasingly widespread utilization of marijuana, there is also a growing complexity of public health policy, regulation, and necessity to further assess the medical indications and adverse long-term effects of marijuana use. Health care providers as well as the general public must be prepared to become familiar and up-to-date with medical literature, legislation, and educational material regarding medical marijuana.
Authors: T D Brisbois; I H de Kock; S M Watanabe; M Mirhosseini; D C Lamoureux; M Chasen; N MacDonald; V E Baracos; W V Wismer Journal: Ann Oncol Date: 2011-02-22 Impact factor: 32.976
Authors: Gale A Richardson; Christopher Ryan; Jennifer Willford; Nancy L Day; Lidush Goldschmidt Journal: Neurotoxicol Teratol Date: 2002 May-Jun Impact factor: 3.763
Authors: Nadia Solowij; Katy A Jones; Megan E Rozman; Sasha M Davis; Joseph Ciarrochi; Patrick C L Heaven; Dan I Lubman; Murat Yücel Journal: Psychopharmacology (Berl) Date: 2011-02-17 Impact factor: 4.530
Authors: Hanan El Marroun; Henning Tiemeier; Eric A P Steegers; Vincent W V Jaddoe; Albert Hofman; Frank C Verhulst; Wim van den Brink; Anja C Huizink Journal: J Am Acad Child Adolesc Psychiatry Date: 2009-12 Impact factor: 8.829
Authors: Li Rita Zhang; Hal Morgenstern; Sander Greenland; Shen-Chih Chang; Philip Lazarus; M Dawn Teare; Penella J Woll; Irene Orlow; Brian Cox; Yonathan Brhane; Geoffrey Liu; Rayjean J Hung Journal: Int J Cancer Date: 2014-06-30 Impact factor: 7.396